Contribution of Syndecans to the Cellular Entry of SARS-CoV-2

Autor: László Szilák, Tamás Letoha, Annamária Letoha, Anett Hudák
Jazyk: angličtina
Rok vydání: 2021
Předmět:
viruses
Angiotensin-Converting Enzyme Inhibitors
spike protein
Syndecan 1
Amiloride
chemistry.chemical_compound
0302 clinical medicine
Biology (General)
Receptor
Internalization
skin and connective tissue diseases
Spectroscopy
cellular entry
media_common
0303 health sciences
General Medicine
Heparan sulfate
Transmembrane protein
3. Good health
Computer Science Applications
Cell biology
Chemistry
Ectodomain
030220 oncology & carcinogenesis
Spike Glycoprotein
Coronavirus

Angiotensin-Converting Enzyme 2
QH301-705.5
Cell Survival
media_common.quotation_subject
coronaviruses
Protein domain
Biology
Article
Catalysis
Cell Line
Inorganic Chemistry
03 medical and health sciences
Protein Domains
Epithelial Sodium Channel Blockers
Humans
Physical and Theoretical Chemistry
QD1-999
Molecular Biology
030304 developmental biology
SARS-CoV-2
Organic Chemistry
fungi
COVID-19
Virus Internalization
syndecans
respiratory tract diseases
body regions
Membrane protein
chemistry
Syndecan-4
Peptides
Receptors
Coronavirus
Zdroj: International Journal of Molecular Sciences
Volume 22
Issue 10
International Journal of Molecular Sciences, Vol 22, Iss 5336, p 5336 (2021)
ISSN: 1422-0067
DOI: 10.3390/ijms22105336
Popis: The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a novel emerging pathogen causing an unprecedented pandemic in 21st century medicine. Due to the significant health and economic burden of the current SARS-CoV-2 outbreak, there is a huge unmet medical need for novel interventions effectively blocking SARS-CoV-2 infection. Unknown details of SARS-CoV-2 cellular biology hamper the development of potent and highly specific SARS-CoV-2 therapeutics. Angiotensin-converting enzyme-2 (ACE2) has been reported to be the primary receptor for SARS-CoV-2 cellular entry. However, emerging scientific evidence suggests the involvement of additional membrane proteins, such as heparan sulfate proteoglycans, in SARS-CoV-2 internalization. Here, we report that syndecans, the evolutionarily conserved family of transmembrane proteoglycans, facilitate the cellular entry of SARS-CoV-2. Among syndecans, the lung abundant syndecan-4 was the most efficient in mediating SARS-CoV-2 uptake. The S1 subunit of the SARS-CoV-2 spike protein plays a dominant role in the virus’s interactions with syndecans. Besides the polyanionic heparan sulfate chains, other parts of the syndecan ectodomain, such as the cell-binding domain, also contribute to the interaction with SARS-CoV-2. During virus internalization, syndecans colocalize with ACE2, suggesting a jointly shared internalization pathway. Both ACE2 and syndecan inhibitors exhibited significant efficacy in reducing the cellular entry of SARS-CoV-2, thus supporting the complex nature of internalization. Data obtained on syndecan specific in vitro assays present syndecans as novel cellular targets of SARS-CoV-2 and offer molecularly precise yet simple strategies to overcome the complex nature of SARS-CoV-2 infection.
Databáze: OpenAIRE